FDA Fast Tracks Sanofi’s Intravitreal Gene Therapy for Neovascular Age-Related Macular Degeneration
September 11th 2025The designation supports expedited development of SAR402663, Sanofi’s one-time gene therapy designed to reduce treatment burden and slow vision loss in patients with wet age-related macular degeneration.
Novartis, BioArctic Reach Deal to Develop BrainTransporter Therapy for Neurodegeneration
August 26th 2025The collaboration provides BioArctic with an upfront payment of $30 million and potential milestone and royalty payments as the companies explore a novel drug candidate for severe neurological disorders.
Why Court Battles Could Alter the Path of Emergency Use Authorizations for Vaccines
August 20th 2025Ron Lanton, partner, Lanton Law, warns that ongoing lawsuits targeting vaccine policy could create ripple effects across FDA decision-making and reshape how future emergency use authorizations are granted.
Lawsuits Likely as Federal Authorities Roll Back Longstanding Vaccine Guidelines
August 19th 2025Ron Lanton, partner, Lanton Law, warns that recent changes to federal vaccine recommendations could trigger extensive litigation as insurers, providers, and patients face new access and coverage challenges.
The Challenges and Advantages of US Healthcare in a Worldwide Perspective
August 18th 2025Rob Abbott, CEO, ISPOR, highlights that the United States excels in areas like cancer screening and advanced medical technology while facing challenges such as rising costs, lack of universal coverage, and health outcomes that lag behind other high-income nations.